Methods of making and using sulfonated carboxylated polysaccharide gelling agents
Abstract
One embodiment of the present invention provides a method of treating a subterranean formation comprising: providing a treatment fluid comprising a sulfonated polysaccharide gelling agent wherein the sulfonated polysaccharide gelling agent is produced by reacting a cyclic sultone with a polysaccharide; and, introducing the treatment fluid into a portion of a subterranean formation. Another embodiment provides a method of treating a subterranean formation, comprising: providing a treatment fluid comprising a carboxylated polysaccharide gelling agent wherein the carboxylated polysaccharide gelling agent is produced by reacting a polysaccharide with at least one of the following: a cyclic lactone or a cyclic phosphonate acid; and introducing the treatment fluid into a portion of a subterranean formation. Another embodiment provides a method of derivatizing a polysaccharide comprising reacting a polysaccharide with at least one of the following: a cyclic sultone, a cyclic lactone, or a cyclic phosphonate acid.
Claims
exact text as granted — not AI-modified1 . A method of treating a subterranean formation comprising:
providing a treatment fluid comprising a sulfonated polysaccharide gelling agent wherein the sulfonated polysaccharide gelling agent is produced by reacting a cyclic sultone with a polysaccharide; and, introducing the treatment fluid into a portion of a subterranean formation.
2 . The method of claim 1 wherein the cyclic sultone comprises at least one of the following: 1,3-propylsultone, 1,4-butylsultone, a derivative of 1,3-propylsultone, a derivative of 1,4-butylsultone, or a derivative of a cyclic sultone.
3 . The method of claim 1 wherein the cyclic sultone and polysaccharide are reacted under alkaline solid phase conditions.
4 . The method of claim 1 wherein the cyclic sultone and polysaccharide are reacted under alkaline aqueous conditions.
5 . The method of claim 1 wherein the treatment fluid further comprises a crosslinking agent and wherein the crosslinking agent comprises at least one of: N,N′-methylenebisacrylamide, boric acid, disodium octaborate tetrahydrate, sodium diborate, a pentaborate, ulexite, colemanite, a compound that can supply zirconium IV ions, a compound that can supply titanium IV ions, an aluminum compound, an antimony compound; a chromium compound; an iron compound; a copper compound; or a zinc compound.
6 . The method of claim 1 wherein the treatment fluid further comprises a gel stabilizer, gel breaker, fluid loss control additive, clay stabilizer, or bactericide.
7 . The method of claim 1 wherein the treatment fluid further comprises particulates.
8 . A method of treating a subterranean formation, comprising:
providing a treatment fluid comprising a carboxylated polysaccharide gelling agent wherein the carboxylated polysaccharide gelling agent is produced by reacting a polysaccharide with at least one of the following: a cyclic lactone or a cyclic phosphonate acid; and introducing the treatment fluid into a portion of a subterranean formation.
9 . The method of claim 8 wherein the cyclic lactone comprises butyrolactone, β-propiolactone, a derivative of butyrolactone, a derivative of β-propiolactone, or a derivative of a cyclic lactone.
10 . The method of claim 8 wherein the cyclic phosphonate acid comprises 1,2-oxaphospholane, a phosphonate ester, or a derivative of a cyclic phosphonic acid.
11 . The method of claim 8 wherein the cyclic lactone and polysaccharide are reacted under alkaline solid phase conditions.
12 . The method of claim 8 wherein the cyclic lactone and polysaccharide are reacted under alkaline aqueous conditions.
13 . The method of claim 8 wherein the treatment fluid further comprises a crosslinking agent and wherein the crosslinking agent comprises at least one of: N,N′-methylenebisacrylamide, boric acid, disodium octaborate tetrahydrate, sodium diborate, a pentaborate, ulexite, colemanite, a compound that can supply zirconium IV ions, a compound that can supply titanium IV ions, an aluminum compound, an antimony compound; a chromium compound; an iron compound; a copper compound; or a zinc compound.
14 . The method of claim 8 wherein the treatment fluid further comprises a gel stabilizer, gel breaker, fluid loss control additive, clay stabilizer, or bactericide.
15 . The method of claim 8 wherein the treatment fluid further comprises particulates.
16 . A method of derivatizing a polysaccharide comprising reacting a polysaccharide with at least one of the following: a cyclic sultone, a cyclic lactone, or a cyclic phosphonate acid.
17 . The method of claim 16 wherein the cyclic sultone comprises at least one of the following: 1,3-propylsultone, 1,4-butylsultone, a derivative of 1,3-propylsultone, a derivative of 1,4-butylsultone, or a derivative of a cyclic sultone.
18 . The method of claim 16 wherein the cyclic lactone comprises butyrolactone, β-propiolactone, a derivative of butyrolactone, a derivative of β-propiolactone, or a derivative of a cyclic lactone.
19 . The method of claim 16 wherein the cyclic phosphonate acid comprises 1,2-oxaphospholane, a phosphonate ester, or a derivative of a cyclic phosphonic acid.
20 . The method of claim 16 wherein the reaction occurs under either alkaline solid phase conditions or alkaline aqueous conditions.Join the waitlist — get patent alerts
Track US2006151172A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.